| 1 |
Maximal initiative dose of simvastatin causing acute renal failure through rhabdomyolysis: Risk factors, pathomechanism and therapy related to a case | [Maximális kezdo dózissal indított és heveny veseelégtelenséggel szövodött, simvastatin indukálta rhabdomyolysis: rizikófaktorok, patomechanizmus és kezelés egy eset kapcsán] |
|
|
| Deme, D., Al-Hadad, A., Varga, T., Szántó, E., Sándor, K., Rakonczai, E. |
|
| Orvosi Hetilap. 2009; 150(6): 265-269 |
|
| [Pubmed] [Google Scholar] |
|
| 2 |
Inflammatory reactions and drug response: Importance of cytochrome P450 and membrane transporters |
|
|
| Dumais, G., Iovu, M., du Souich, P. |
|
| Expert Review of Clinical Pharmacology. 2008; 1(5): 627-647 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism |
|
|
| Golomb, B.A., Evans, M.A. |
|
| American Journal of Cardiovascular Drugs. 2008; 8(6): 373-418 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Simvastatin-induced rhabdomyolysis: a case study on clinical-decision making based on the evidence-based medicine approach |
|
|
| Koskinas K, Tzellos TG, Gougoulias K, et al. |
|
| ARCHIVES OF MEDICAL SCIENCE. 2007; 3(3): 267-271 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
First reports of adverse drug reactions (ADRs) in recent weeks |
|
|
| |
|
| Drugs and Therapy Perspectives. 2005; 21(3): 21-22 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Adverse effects of statins: An update |
|
|
| Karthikeyan, V.J. |
|
| Adverse Drug Reaction Bulletin. 2005; 233: 895-898 |
|
| [Pubmed] [Google Scholar] |
|
